EDGAR·FLOW

Amesite Inc. — Form 8-K

Filed November 17, 2026 · analyzed by the 8-K Agent
8-K ▲ Likely positive significance 72/100
What the filing says
Amesite Inc. announced a new enterprise contract with a healthcare organization serving approximately 2,000 patients, expanding its NurseMagic platform adoption among larger healthcare organizations. The contract follows other recent wins including a 2,700-census customer in May 2026 and extends the company's footprint into rural Medicare and Medicaid markets. No specific revenue amount, contract value, or financial terms were disclosed in the filing.
Why this rating

Material customer win for $15.4M company; demonstrates scale progress (4x median census growth 2025–2026). No revenue figure disclosed limits quantification. Positive trajectory indicator but execution risk remains.

Tradability signal
NO TRADE

No trade: positive news with only -2.7% moved so far — good news prices in within seconds and long-side continuation has shown no measured edge (this cell: -0.26% over 4 hrs, n=543). (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it positive)
before filing · preread
$0.55 ▲ 4.94%
at our read · unknown
$0.53
+10 min · unknown
$0.44 ▼ 16.52%
+30 min · unknown
$0.48 ▼ 8.73%
+1 hr · unknown
$0.49 ▼ 5.89%
+4 hrs · unknown
$0.61 ▲ 16.03%

The stock had already moved -4.71% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ AMST · stock on Yahoo Finance ↗

See more from November 17, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.